Alkaline phosphatase and its isoenzyme activity for the evaluation of bone metabolism in children receiving anticonvulsant monotherapy

Seizure

Volumn 11, Issue 6, 2002, Pages 377-380

  Voudris, Konstantinos ^a   Moustaki, Maria ^b   Zeis, Petros M ^b   Dimou, Stamatia ^a   Vagiakou, Eleni ^c   Tsagris, Basilios ^b   Skardoutsou, Angeliki ^b  

^a P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

Author keywords

Alkaline phosphatase; Alkaline phosphatase isoenzymes; Anticonvulsant drugs; Bone metabolism; Epileptic children

Indexed keywords

ALKALINE PHOSPHATASE; ANTICONVULSIVE AGENT; BIOLOGICAL MARKER; CARBAMAZEPINE; INTESTINE ENZYME; ISOENZYME; LIVER ENZYME; PHENOBARBITAL; VALPROIC ACID;

ADOLESCENT; AGE; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ANTICONVULSANT THERAPY; ARTICLE; BONE METABOLISM; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; GENDER; HUMAN; INFANT; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; MONOTHERAPY; OUTPATIENT; PATIENT SELECTION; PRIORITY JOURNAL; SEIZURE; SOUTHERN EUROPE; SUN EXPOSURE;

EID: 0036747299     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.2002.0671     Document Type: Article

References (19)

1. Kazamatsuri, H. Elevated serum alkaline phosphatase levels in epilepsy during diphenylhydantoin therapy. New England Journal of Medicine 1970; 283: 1411-1412.
2. Winnacker, J. L., Yeager, H., Saunders, J. A., Russell, B. and Anast, C. S. Rickets in children receiving anticonvulsant drugs. Biochemical and hormonal markers. American Journal of Diseases in Children 1977; 131: 286-290.
3. O'Hare, J. A., Duggan, B., O'Driscoll, D. and Callaghan, N. Biochemical evidence for osteomalacia with carbamazepine therapy. Acta Neurologica Scandinavica 1980; 62: 282-286.
4. Okesina, A. B., Donaldson, D. and Lascelles, P. T. Isoenzymes of alkaline phosphatase in epileptic patients receiving carbamazepine monotherapy. Journal of Clinical Pathology 1991; 44: 480-482.
5. Nijhawan, R., Wierzbicki, A. S., Tozer, R., Lascelles, P. T. and Patsalos, P. N. Antiepileptic drugs, hepatic enzyme induction and raised serum alkaline phosphatase isoenzymes. International Journal of Clinical Pharmacology Research 1990; 10: 319-323.
6. Rico, H., Varela de Seijas, E., Arias, J. A. and Cabranes, J. A. Long-term influence of anticonvulsant agents on calcitonin, parathyroid hormone and osteocalcin. European Neurology 1992; 32: 324-327.
7. Collins, N., Maher, J., Cole, M., Baker, M. and Callaghan, N. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. The Quarterly Journal of Medicine 1991; 78: 113-122.
8. Filardi, S., Guerreiro, C. A., Magna, L. A. and Marques Neto, J. F. Bone mineral density, vitamin D and anticonvulsant therapy. Arquivos de Neuropsiquiatria 2000; 58: 616-620.
9. Mosekilde, L. and Melsen, F. Anticonvulsant osteomalacia determined by quantitative analysis of bone changes. Population study and possible risk factors. Acta Medica Scandinavica 1976; 199: 349-355.
10. Poskitt, E. M., Cole, T. J. and Lawson, D. E. Diet, sunlight, and 25-hydroxy vitamin D in healthy children and adults. British Medical Journal 1979; 1: 221-223.
11. Holmberg, I. and Larsson, A. Seasonal variation of vitamin D3 and 25-hydroxy vitamin D3 in human serum. Clinica Chimica Acta 1980; 100: 173-174.
12. Erbayat, A. E., Serdaroglu, A., Tumer, L., Gucuyener, K. and Hasanoglu, A. Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. Journal of Pediatric Endocrinology and Metabolism 2000; 13: 933-939.
13. Kafali, G., Erselcan, T. and Tanzer, F. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clinical Pediatrics 1999; 38: 93-98.
14. Christiansen, C., Rodbro, P. and Lund, M. Incidence of anti-convulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. British Medical Journal 1973; 4: 695-701.
15. Meyer-Sabellek, W., Sinha, P. and Kottgen, E. Alkaline phosphatase: laboratory and clinical implications. Journal of Chromatography 1988; 429: 419-444.
16. Richens, A. and Rowe, D. J. Disturbance of calcium metabolism by anticonvulsant drugs. British Medical Journal 1970; 4: 73-76.
17. Kruse, K., Bartels, H. and Gunther, H. Serum alkaline phosphatase isoenzymes in epileptic children receiving anti-convulsant drugs. European Journal of Pediatrics 1977; 126: 237-242.
18. Verrotti, A., Greco, R., Morgese, G. and Chiarelli, F. Increased bone turnover in epileptic patients treated with carbamazepine. Annals of Neurology 2000; 47: 385-388.
19. Hahn, T. J., Hendin, B. A., Scharp, C. R., Boisseau, V. C. and Haddad, J. G. Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy. New England Journal of Medicine 1975; 292: 550-554.